Advanced

The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin

Huang, Xiaoli LU ; Borgström, Björn LU ; Stegmayr, John LU ; Abassi, Yasmin LU ; Kruszyk, Monika; Leffler, Hakon LU ; Persson, Lo LU ; Albinsson, Sebastian LU ; Massoumi, Ramin LU and Scheblykin, Ivan G. LU , et al. (2018) In ACS Central Science 4(6). p.760-767
Abstract

Tumors are phenotypically heterogeneous and include subpopulations of cancer cells with stemlike properties. The natural product salinomycin, a K+-selective ionophore, was recently found to exert selectivity against such cancer stem cells. This selective effect is thought to be due to inhibition of the Wnt signaling pathway, but the mechanistic basis remains unclear. Here, we develop a functionally competent fluorescent conjugate of salinomycin to investigate the molecular mechanism of this compound. By subcellular imaging, we demonstrate a rapid cellular uptake of the conjugate and accumulation in the endoplasmic reticulum (ER). This localization is connected to induction of Ca2+ release from the ER into the... (More)

Tumors are phenotypically heterogeneous and include subpopulations of cancer cells with stemlike properties. The natural product salinomycin, a K+-selective ionophore, was recently found to exert selectivity against such cancer stem cells. This selective effect is thought to be due to inhibition of the Wnt signaling pathway, but the mechanistic basis remains unclear. Here, we develop a functionally competent fluorescent conjugate of salinomycin to investigate the molecular mechanism of this compound. By subcellular imaging, we demonstrate a rapid cellular uptake of the conjugate and accumulation in the endoplasmic reticulum (ER). This localization is connected to induction of Ca2+ release from the ER into the cytosol. Depletion of Ca2+ from the ER induces the unfolded protein response as shown by global mRNA analysis and Western blot analysis of proteins in the pathway. In particular, salinomycin-induced ER Ca2+ depletion up-regulates C/EBP homologous protein (CHOP), which inhibits Wnt signaling by down-regulating β-catenin. The increased cytosolic Ca2+ also activates protein kinase C, which has been shown to inhibit Wnt signaling. These results reveal that salinomycin acts in the ER membrane of breast cancer cells to cause enhanced Ca2+ release into the cytosol, presumably by mediating a counter-flux of K+ ions. The clarified mechanistic picture highlights the importance of ion fluxes in the ER as an entry to inducing phenotypic effects and should facilitate rational development of cancer treatments.

(Less)
Please use this url to cite or link to this publication:
author
, et al. (More)
(Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
ACS Central Science
volume
4
issue
6
pages
8 pages
publisher
The American Chemical Society
external identifiers
  • scopus:85049122492
ISSN
2374-7943
DOI
10.1021/acscentsci.8b00257
language
English
LU publication?
yes
id
9b1bd251-cd6a-4870-96ef-f836805a7130
date added to LUP
2018-07-13 14:53:55
date last changed
2018-10-21 04:57:15
@article{9b1bd251-cd6a-4870-96ef-f836805a7130,
  abstract     = {<p>Tumors are phenotypically heterogeneous and include subpopulations of cancer cells with stemlike properties. The natural product salinomycin, a K<sup>+</sup>-selective ionophore, was recently found to exert selectivity against such cancer stem cells. This selective effect is thought to be due to inhibition of the Wnt signaling pathway, but the mechanistic basis remains unclear. Here, we develop a functionally competent fluorescent conjugate of salinomycin to investigate the molecular mechanism of this compound. By subcellular imaging, we demonstrate a rapid cellular uptake of the conjugate and accumulation in the endoplasmic reticulum (ER). This localization is connected to induction of Ca<sup>2+</sup> release from the ER into the cytosol. Depletion of Ca<sup>2+</sup> from the ER induces the unfolded protein response as shown by global mRNA analysis and Western blot analysis of proteins in the pathway. In particular, salinomycin-induced ER Ca<sup>2+</sup> depletion up-regulates C/EBP homologous protein (CHOP), which inhibits Wnt signaling by down-regulating β-catenin. The increased cytosolic Ca<sup>2+</sup> also activates protein kinase C, which has been shown to inhibit Wnt signaling. These results reveal that salinomycin acts in the ER membrane of breast cancer cells to cause enhanced Ca<sup>2+</sup> release into the cytosol, presumably by mediating a counter-flux of K<sup>+</sup> ions. The clarified mechanistic picture highlights the importance of ion fluxes in the ER as an entry to inducing phenotypic effects and should facilitate rational development of cancer treatments.</p>},
  author       = {Huang, Xiaoli and Borgström, Björn and Stegmayr, John and Abassi, Yasmin and Kruszyk, Monika and Leffler, Hakon and Persson, Lo and Albinsson, Sebastian and Massoumi, Ramin and Scheblykin, Ivan G. and Hegardt, Cecilia and Oredsson, Stina and Strand, Daniel},
  issn         = {2374-7943},
  language     = {eng},
  month        = {06},
  number       = {6},
  pages        = {760--767},
  publisher    = {The American Chemical Society},
  series       = {ACS Central Science},
  title        = {The Molecular Basis for Inhibition of Stemlike Cancer Cells by Salinomycin},
  url          = {http://dx.doi.org/10.1021/acscentsci.8b00257},
  volume       = {4},
  year         = {2018},
}